Molecular Therapy: Nucleic Acids (Sep 2023)

MicroRNA-142a-3p regulates neurogenic skeletal muscle atrophy by targeting Mef2a

  • Xinyi Gu,
  • Shen Wang,
  • Dongdong Li,
  • Bo Jin,
  • Zhidan Qi,
  • Jin Deng,
  • Chen Huang,
  • Xiaofeng Yin

Journal volume & issue
Vol. 33
pp. 191 – 204

Abstract

Read online

Peripheral nerve injury can lead to progressive muscle atrophy and poor motor function recovery, which is a difficult point of treatment, and the mechanism needs to be further explored. In previous studies, we found that miR-142a-3p was significantly upregulated and persistently highly expressed in denervated mouse skeletal muscle. Here, we show that overexpression of miR-142a-3p inhibited the growth and differentiation of C2C12 myoblast, while knockdown of miR-142a-3p had a promoting effect. In vitro, knockdown of miR-142a-3p in denervated mouse skeletal muscle effectively increased proliferating muscle satellite cells and ameliorated muscle atrophy. Mechanistically, the myoregulator Mef2a was proved to be an important downstream target of miR-142a-3p, and miR-142a-3p regulates skeletal muscle differentiation and regeneration by inhibiting the expression of Mef2a. The co-knockdown of Mef2a and miR-142a-3p effectively alleviated or offset the biological effects of miR-142a-3p knockdown. In conclusion, our data revealed that miR-142a-3p regulates neurogenic skeletal muscle atrophy by targeting Mef2a.

Keywords